Labour, Induced Clinical Trial
Official title:
Membrane Sweeping Versus Transcervical Foley Catheter for Induction of Labour in Women With Previous Caesarean Delivery
Verified date | October 2018 |
Source | Ministry of Health, Malaysia |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Nowadays, more and more women embark on pregnancy with previous Caesarean scar. One in five
pregnancies requires induction of labour. The use of non-pharmacological methods (methods
without using medication) has been gaining popularity for women who are not good candidates,
such as women with previous Caesarean scar, for an induction with medications such as
prostaglandin. Labour induction with prostaglandin carries higher risk of uterine rupture and
thus it is not routinely offered to women with previous Caesarean delivery in Sibu Hospital.
Non-pharmacological methods of induction of labour appear to be safe in women with previous
Caesarean delivery. However, various methods are available and the efficacy among them remain
in doubt.
In Sibu Hospital, membrane sweeping, which is a type of non-pharmacological method, is
routinely offered to women with previous Caesarean delivery who require induction of labour.
However, membrane sweeping may not exert its labour induction effect immediately and the
delivery may be delayed by up to 8 days. This may render a proportion of women to resort to
repeated Caesarean section for failed induction.
Transcervical Foley catheter insertion is another non-pharmacological methods for labour
induction. Foley catheter, which is made from latex rubber, is inserted into the womb. The
balloon will be inflated and this put pressure on the cervix and encourages dilatation. This
method may successfully stimulates labour and the catheter falls out once the cervix dilates
to 3 centimeters.
The benefits of the Foley catheter:
- A favourable and safe option for mothers who are hoping for a vaginal birth after
Caesarean. It is estimated that 4-7 in 10 women with previous Caesarean undergoing
labour induction with Foley catheter will have successful vaginal births.
- Cause the cervix to mechanically open without involving medication.
- Reduced risk of uterine rupture compared to induction with prostaglandin.
- Less risk of fetal distress compared to induction with prostaglandin.
The risks of Foley catheter:
- Vaginal bleeding (1.8%)
- Pain requiring removal of catheter (1.7%)
- Baby moving from head down to breech (1.3%)
- Fever (1%) which is lower than induction with prostaglandin.
- The risk of uterine rupture is similar to women undergoing spontaneous vaginal birth
after Caesarean.
The aim of this study is to compare the effectiveness of two types of non-pharmacological
methods, ie. membrane sweeping and transcervical Foley catheter for induction of labour in
women with previous Caesarean delivery.
Status | Completed |
Enrollment | 60 |
Est. completion date | September 1, 2018 |
Est. primary completion date | August 30, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Pregnant women with one previous Caesarean section who are admitted to Sibu Hospital for induction of labor (IOL) will be recruited. The inclusion criteria are age at least 18 years old, gestational age = 37 weeks, singleton pregnancy, reassuring fetal status and modified Bishop score = 6. Exclusion Criteria: - Ruptured membranes, intrauterine death, polyhydramnios, severe fetal anomalies, and multiple pregnancy. - Contraindications for IOL eg. placenta previa, suspected macrosomia, suspected cephalopelvic disproportion, non-cephalic presentation, and obstructive pelvic masses. |
Country | Name | City | State |
---|---|---|---|
Malaysia | Sibu Hospital | Sibu | Sarawak |
Lead Sponsor | Collaborator |
---|---|
Ministry of Health, Malaysia |
Malaysia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Achievement of favourable cervix (Bishop score of 8 or more) within 48 hours of induction of labour | The number of subjects who achieve Bishop score of 8 or more within 48 hours of induction of labour | From the time of commencing induction until the time whereby the cervix becomes favourable (Bishop score of 8 or more), assessed up to 48 hours | |
Secondary | Induction outcomes: Improvement of modified Bishop score at interval of 24 hours after induction | The difference of modified Bishop score between pre-induction and 24 hours post-induction. The score is assessed based on the station of the presentation, os dilation, and effacement (or length), position and consistency of the cervix. Score ranges from 0 to 12. A score of 8 or more generally indicates that the cervix is ripe/favourable. | From the time of commencing induction till 24 hours after induction | |
Secondary | Induction outcomes: Improvement of modified Bishop score at interval of 48 hours after induction | The difference of modified Bishop score between pre-induction and 48 hours post-induction. The score is assessed based on the station of the presentation, os dilation, and effacement (or length), position and consistency of the cervix. Score ranges from 0 to 12. A score of 8 or more generally indicates that the cervix is ripe/favourable. | From the time of commencing induction till 48 hours after induction | |
Secondary | Delivery outcomes: Mode of delivery | Final mode of delivery ie. vaginal delivery and Caesarean section | At time of delivery | |
Secondary | Delivery outcomes: Duration of oxytocin augmentation | Duration of oxytocin augmentation during intrapartum period | From the time of administrating oxytocin augmentation until the time of delivery, assessed up to 16 hours | |
Secondary | Delivery outcomes: Induction to vaginal delivery interval | Duration between the time of induction of labour and vaginal delivery | From the time of induction of labour until the time of vaginal delivery, assessed up to 72 hours | |
Secondary | Delivery outcomes: Amniotomy to vaginal delivery interval | Duration between the time of amniotomy and vaginal delivery | From the time of amniotomy till the time of vaginal delivery, assessed up to 16 hours | |
Secondary | Maternal outcomes: Uterine hyperstimulation | The occurrence of uterine hyperstimulation (> 5 contractions per 10 minutes for at least 20 minutes or a contraction lasting at least 2 minutes with/without abnormal fetal heart rate) during labour process | From the time of induction until the time of delivery, assessed up to 72 hours | |
Secondary | Maternal outcomes: Uterine rupture | The occurrence of uterine rupture during labour process | From the time of induction until the time of delivery, assessed up to 72 hours | |
Secondary | Maternal outcomes: Post-partum haemorrhage | The occurrence of post-partum haemorrhage (estimated blood loss = 500 ml) after delivery | From the time of delivery until the time of discharge, assessed up to 48 hours | |
Secondary | Maternal outcomes: Maternal pyrexia | The occurrence of maternal fever (temperature >38.0 °C once, or 37.5 °C on two occasions 2 hours apart) during labour process | From the time of induction until the time of delivery, assessed up to 72 hours | |
Secondary | Maternal outcomes: Duration of hospitalisation | To measure the duration of hospitalisation required | From the time of induction until the time of discharge home following delivery, assessed up to 120 hours | |
Secondary | Neonatal outcomes: 5-minutes APGAR score | To measure the APGAR score of the newborn at 5 minutes of life, scores range between 0 to 10, score < 7 is considered abnormal | Upon the baby is delivered, assessed up to 5 minutes of life | |
Secondary | Neonatal outcomes: cord pH | To obtain umbilical cord blood of the newborn for pH measurement upon birth, normal levels are 7.25 and above, pH < 7.25 is abnormal and < 7.0 is considered pathological acidosis due to perinatal asphyxia | Upon baby is delivered, assessed immediately |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02516631 -
Comparative Bioavailability Study of Two Misoprostol Formulations
|
Phase 1 | |
Completed |
NCT03489928 -
Misoprostol Labour Induction Study
|
Phase 3 |